181 related articles for article (PubMed ID: 14578863)
1. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
[TBL] [Abstract][Full Text] [Related]
2. Mapping the amplification of EIF3S3 in breast and prostate cancer.
Nupponen NN; Isola J; Visakorpi T
Genes Chromosomes Cancer; 2000 Jun; 28(2):203-10. PubMed ID: 10825005
[TBL] [Abstract][Full Text] [Related]
3. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
5. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
6. Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.
Saramäki O; Willi N; Bratt O; Gasser TC; Koivisto P; Nupponen NN; Bubendorf L; Visakorpi T
Am J Pathol; 2001 Dec; 159(6):2089-94. PubMed ID: 11733359
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization.
Sakakura C; Hagiwara A; Taniguchi H; Yamaguchi T; Yamagishi H; Takahashi T; Koyama K; Nakamura Y; Abe T; Inazawa J
Br J Cancer; 1999 Aug; 80(12):2034-9. PubMed ID: 10471057
[TBL] [Abstract][Full Text] [Related]
8. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization.
Marchio A; Meddeb M; Pineau P; Danglot G; Tiollais P; Bernheim A; Dejean A
Genes Chromosomes Cancer; 1997 Jan; 18(1):59-65. PubMed ID: 8993981
[TBL] [Abstract][Full Text] [Related]
9. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
[TBL] [Abstract][Full Text] [Related]
10. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
Kusano N; Shiraishi K; Kubo K; Oga A; Okita K; Sasaki K
Hepatology; 1999 Jun; 29(6):1858-62. PubMed ID: 10347130
[TBL] [Abstract][Full Text] [Related]
11. Infrequent amplification of JUN in hepatocellular carcinoma.
Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
[TBL] [Abstract][Full Text] [Related]
12. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
Park SJ; Jeong SY; Kim HJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
[TBL] [Abstract][Full Text] [Related]
13. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
Yasui K; Arii S; Zhao C; Imoto I; Ueda M; Nagai H; Emi M; Inazawa J
Hepatology; 2002 Jun; 35(6):1476-84. PubMed ID: 12029633
[TBL] [Abstract][Full Text] [Related]
14. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
[TBL] [Abstract][Full Text] [Related]
15. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
[TBL] [Abstract][Full Text] [Related]
16. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
Schlaeger C; Longerich T; Schiller C; Bewerunge P; Mehrabi A; Toedt G; Kleeff J; Ehemann V; Eils R; Lichter P; Schirmacher P; Radlwimmer B
Hepatology; 2008 Feb; 47(2):511-20. PubMed ID: 18161050
[TBL] [Abstract][Full Text] [Related]
17. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
Slagle BL; Zhou YZ; Butel JS
Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.
Nupponen NN; Porkka K; Kakkola L; Tanner M; Persson K; Borg A; Isola J; Visakorpi T
Am J Pathol; 1999 Jun; 154(6):1777-83. PubMed ID: 10362802
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]